A. B. Rowaiye, “RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION”, Afr. J. Infect. Dis., vol. 16, no. 2, pp. 80–96, May 2022.